Oxygen-Generating Transdermal Nanoplatform Codelivering BRD4 Proteolysis-Targeting Chimera/Verteporfin/CaO 2 Synergistically Remodels Immunosuppressive Melanoma Microenvironment to Potentiate Combination Immunotherapy
ACS Nano · 22.07.2025 · 19 (28) · 25830-25850
DOI: 10.1021/acsnano.5c04580 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 08.07.2025. Verfasst von Mingli Wei und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, Liaoning, China. Hauptthemen laut MEDLINE: Immunotherapy, Nanoparticles, Oxygen, Verteporfin. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Department of Education of Liaoning Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, Liaoning, China.
- School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang 110016, Liaoning, China.
ORCID-Profile: Haibing He, Xing Tang, Yu Zhang
Förderung
- National Key Research and Development Program of China
- Department of Education of Liaoning Province
- National Natural Science Foundation of China
Zitieren
APA
Wei, M., Yin, T., Chu, C., Ji, M., Zhao, J., Liang, X., Bi, X., Gou, J., He, H., Tang, X., & Zhang, Y. (2025). Oxygen-Generating Transdermal Nanoplatform Codelivering BRD4 Proteolysis-Targeting Chimera/Verteporfin/CaO 2 Synergistically Remodels Immunosuppressive Melanoma Microenvironment to Potentiate Combination Immunotherapy. ACS Nano, 19(28), 25830-25850. https://doi.org/10.1021/acsnano.5c04580
Vancouver
Wei M, Yin T, Chu C, Ji M, Zhao J, Liang X, et al. Oxygen-Generating Transdermal Nanoplatform Codelivering BRD4 Proteolysis-Targeting Chimera/Verteporfin/CaO 2 Synergistically Remodels Immunosuppressive Melanoma Microenvironment to Potentiate Combination Immunotherapy. ACS Nano. 2025;19(28):25830-25850. doi:10.1021/acsnano.5c04580
BibTeX
@article{Wei2025,
author = {Wei, Mingli and Yin, Tian and Chu, Chenxiao and Ji, Muse and Zhao, Jiansong and Liang, Xinxin and Bi, Xiaoshuang and Gou, Jingxin and He, Haibing and Tang, Xing and Zhang, Yu},
title = {Oxygen-Generating Transdermal Nanoplatform Codelivering BRD4 Proteolysis-Targeting Chimera/Verteporfin/CaO 2 Synergistically Remodels Immunosuppressive Melanoma Microenvironment to Potentiate Combination Immunotherapy},
journal = {ACS Nano},
year = {2025},
volume = {19},
number = {28},
pages = {25830--25850},
doi = {10.1021/acsnano.5c04580}
}
EUVIMED